Literature DB >> 31653154

Clinico-Pathological Characteristics and Mutational Analysis of Gastrointestinal Stromal Tumors from India: A Single Institution Experience.

Sachin Minhas1, Sunita Bhalla2, Mayank Jauhri1, Madhusudan Ganvir1, Shyam Aggarwal1.   

Abstract

BACKGROUND: Gastrointestinal stromal tumor (GIST) is the most common type of mesenchymal neoplasm of gastrointestinal tract. The incidence of GIST in India is not known and its treatment strategy in our country is largely derived from studies in other global populations. Some of the most important features of this type of cancer include its size, site of origin, mitotic index, histology and Immunohistochemistry. In this report we have studied these parameters in the Indian GIST patients presenting at our center. Additionally, we have also studied the mutational spectrum of these GISTs by next generation sequencing.
METHODS: Thirty one Indian patients of GIST were enrolled in this study and information regarding age, gender, tumor location and size was collected from their records. Immunohistochemistry studies were performed by the pathologist. Mutational analysis of these samples was performed by next generation sequencing. RESULTS AND DISCUSSION: The most common site of GIST occurrence in our study was stomach. The tumor size for all 31 patients ranged between 0.6 cms to 20 cms. A spindle-cell pattern was present in 24 out of 31 of the cases. 29 out of 31 subjects were positive for CD117 expression. C-KIT was the most highly mutated gene indentified in our patients. Apart from these findings we observed many similarities as well as dissimilarities between the results of our study and literature published previously.
CONCLUSIONS: The dissimilarities in the results of our study and published literature could be attributed to the genetic or ethnic differences that exist between the Indian population and other global populations. The results of our study warrant a need to conduct studies of GIST in a much larger population of India. Such large scale studies may also help in better treatment and/or prevention of GIST in developing countries like India.

Entities:  

Keywords:  CD117; GIST; Gastric; Oncology; c-KIT

Mesh:

Substances:

Year:  2019        PMID: 31653154      PMCID: PMC6982673          DOI: 10.31557/APJCP.2019.20.10.3051

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  12 in total

Review 1.  Gastrointestinal stromal tumors: pathology and prognosis at different sites.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Semin Diagn Pathol       Date:  2006-05       Impact factor: 3.464

Review 2.  Management of malignant gastrointestinal stromal tumours.

Authors:  Heikki Joensuu; Christopher Fletcher; Sasa Dimitrijevic; Sandra Silberman; Peter Roberts; George Demetri
Journal:  Lancet Oncol       Date:  2002-11       Impact factor: 41.316

Review 3.  Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Arch Pathol Lab Med       Date:  2006-10       Impact factor: 5.534

Review 4.  Gastrointestinal stromal tumors (GISTs): a review.

Authors:  Sonja E Steigen; Tor J Eide
Journal:  APMIS       Date:  2009-02       Impact factor: 3.205

Review 5.  Gastrointestinal stromal tumour.

Authors:  Brian P Rubin; Michael C Heinrich; Christopher L Corless
Journal:  Lancet       Date:  2007-05-19       Impact factor: 79.321

Review 6.  Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.

Authors:  J Lasota; M Miettinen
Journal:  Histopathology       Date:  2008-02-28       Impact factor: 5.087

Review 7.  Best practices in diagnostic immunohistochemistry: spindle cell neoplasms of the gastrointestinal tract.

Authors:  Matthew S Turner; Jeffrey D Goldsmith
Journal:  Arch Pathol Lab Med       Date:  2009-09       Impact factor: 5.534

8.  Single-center experience of surgically resected gastrointestinal stromal tumors: A report of six cases, including a rare case involving the lower esophagus.

Authors:  Bilal O Al-Jiffry; Hisham M Allam; Mohammed Hatem
Journal:  Oncol Lett       Date:  2014-12-11       Impact factor: 2.967

9.  Indian Council of Medical Research consensus document for the management of gastrointestinal stromal tumors.

Authors:  Shailesh V Shrikhande; Bhawna Sirohi; Savio G Barreto; Raju T Chacko; Purvish M Parikh; Jeremy Pautu; Supreeta Arya; Prachi Patil; Srinivas C Chilukuri; B Ganesh; Tanvir Kaur; Deepak Shukla; Goura Shankar Rath
Journal:  Indian J Med Paediatr Oncol       Date:  2014-10

10.  Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece.

Authors:  Leonidas Mavroeidis; Vassiliki Metaxa-Mariatou; Alexandra Papoudou-Bai; Angeliki Maria Lampraki; Lida Kostadima; Ilias Tsinokou; George Zarkavelis; Alexandra Papadaki; Dimitrios Petrakis; Stefania Gκoura; Eleftherios Kampletsas; George Nasioulas; Anna Batistatou; George Pentheroudakis
Journal:  ESMO Open       Date:  2018-04-06
View more
  1 in total

1.  Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in KIT, ERBB2, KRAS, and TP53 in 30% of Thymic Carcinomas.

Authors:  Adam Szpechcinski; Malgorzata Szolkowska; Sebastian Winiarski; Urszula Lechowicz; Piotr Wisniewski; Magdalena Knetki-Wroblewska
Journal:  Cancers (Basel)       Date:  2022-07-12       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.